Private Equity
Lexington, Massachusetts-based Ribon Therapeutics, a biotechnology company, has raised $65 million in Series B financing. Novartis Venture Fund led the round with participation from JJDC, Celgene Corporation, The Column Group, Deerfield Management, U.S. Venture Partners, Osage University Partners, Takeda Ventures and Euclidean Capital.
1 min read · 04 January 2019
Sophia Genetics, a Swiss health tech company, has raised $77 million in funding. Generation Investment Management led the round with participation from other investors that included Idinvest Partners, Balderton Capital and Alychlo.
1 min read · 04 January 2019
Oculis, a Swiss developer of ophthalmic drugs, has raised CHF 15.5 million (about $15.6 million) in funding. Tekla Capital Management LLC led the round with participation from other investors that included Nan Fung Life Sciences.
5 min read · 04 January 2019
Activity in Canada’s initial public offering (IPO) market had a "respectable" finish in 2018 despite volatility and uncertainty, according to a survey by PwC Canada. In all, 54 new equity issues on Canadian exchanges raised $2.2 billion last year, PwC found. That is less than half of the $5.1 billion generated by 37 IPOs in 2017. Last year's largest IPO was the US$462 million Canada-U.S. listing of Ceridian HCM Holding Inc, a human-resources-software provider backed by Thomas H. Lee Partners and Cannae Investors. In second spot was the $242 million IPO of Marc Anthony Cosmetics Inc, a beauty specialist backed by TA Associates.
4 min read · 03 January 2019
Seattle-based Immusoft Corporation, a cell therapy company, has raised $20 million in Series B financing. The investors included Breakout Ventures, Alexandria Venture Investments, RBV Capital, DEFTA Partners and Mesa Verde Venture Partners.
1 min read · 03 January 2019
Ostara Nutrient Recovery Technologies Inc, a Vancouver-based provider of nutrient management solutions, has raised a preferred equity financing of more than $15 million (US$11 million). The round was led by U.K.-based Wheatsheaf Group Ltd and U.S. energy venture capital firm VantagePoint Capital. They were joined by other returning investors. Founded in 2005, Ostara's technology recovers phosphorus and nitrogen from industrial, agricultural and municipal water treatment facilities and converts them into sustainable fertilizer. Led by President and CEO Dan Parmar, the company will use the funds raised to accelerate scaling of fertilizer production, support global growth, and hire new talent.
3 min read · 03 January 2019
March Capital Partners has raised a $156.6 million second venture-capital fund and a $145.4 million second opportunity fund, according to a pair of filings with the SEC.
1 min read · 03 January 2019
Revered venture capitalist Mary Meeker is seeking to raise $1.25 billion on a hard cap of $1.5 billion for a debut fund for her new venture capital firm, Bond, according to a report from Axios.
1 min read · 03 January 2019
Vancouver, British Columbia-based Ostara, a provider of nutrient management solutions to farms, municipalities and industries, has raised $11 million in funding. Wheatsheaf Group Limited and VantagePoint Capital Partners led the round. The capital will be used to scale the company's fertilizer production as well as support its expansion.
3 min read · 03 January 2019
Triventures ARC, a venture capital arm of the ARC Innovation Center at Sheba Medical Center, an Israeli hospital, is seeking to raise $45 million for a fund focused on seed investments in healthcare innovations. Triventures, which is based in Herzliya, Israel and Menlo Park, California, will manage Triventures ARC.
6 min read · 03 January 2019
